- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis2008 | First Faculty of Medicine
- The long-term outcomes of patients with juvenile rheumatoid arthritisPublication without faculty affiliation
- 48-week data from the study of adalimumab in children with juvenile rheumatoid arthritis (JRA)Publication without faculty affiliation
- Long-term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): 48-week resultsPublication without faculty affiliation
- Knee Joint Synovectomy in the Treatment of Juvenile Rheumatoid Arthritis2002 | First Faculty of Medicine
- Adalimumab for the treatment of patients with juvenile rheumatoid arthritis: safety and efficacy after conversion from body-surface-area dosing to weight-based fixed dosingPublication without faculty affiliation
- Methodological aspects of examination of red blood cells methotrexate levels in patients with psoriasis and juvenile rheumatoid arthritis +1Publication without faculty affiliation
- Long-term efficacy and safety adalimumab in children with juvenile rheumatoid arthritis (JRA): converting from body-surface-area dosing to weight-based fixed dosing in the open-label extension (OLE) of a phase III studyPublication without faculty affiliation